Detailansicht

Wissensnetz

Person

Leena Bruckner-Tuderman (1952-)

Hautärztin

Name	Leena Bruckner-Tuderman
Zeit	1952- (Lebensdaten)
Ort	Oulu (Geburtsort) Freiburg im Breisgau (Wirkungsort) Finnland
Akademischer Grad bzw. Titel	Prof. Dr.
Beruf	Hautärztin (charakteristischer Beruf) Hochschullehrerin
Variante	Leena Kaarina Bruckner-Tuderman Leena Bruckner- Tuderman L. Bruckner-Tuderman Leena Tuderman (früherer Name)
Beziehung	Klinik für Dermatologie und Venerologie Deutsche Akademie der Naturforscher Leopoldina (Mitglied, Matrikelnummer 07170) (2007-)
Weitere Angaben	Ärztliche Direktorin der Universitäts-Hautklinik Freiburg. Vizepräsidentin der DFG
Datensatztyp	Person
GND-Nummer	1088453562
Datensatz-ID	1088453562
Beteiligt an alle anzeigen Dipeptidyl peptidase-4-mediated fibronectin processing evokes a pro-fibrotic extracellular matrix Dipeptidylpeptidase-4-mediated fibronectin interaction promotes deposition of a profibrotic extracellular matrix Pioneers in dermatology and venereology: an interview with Professor Leena Bruckner‐Tuderman Safety and tolerability of losartan to treat recessive dystrophic epidermolysis bullosa in children (REFLECT): an open-label, single-arm, phase 1/2 trial Identification of PCPE-2 as the endogenous specific inhibitor of human BMP-1/tolloid-like proteinases Identification of PCPE-2 as the endogenous specific inhibitor of human BMP-1/tolloid-like proteinases Pro‐inflammatory immunity supports fibrosis advancement in epidermolysis bullosa: intervention with Ang‐(1‐7) Diversity ofmechanisms underlying latent TGF-[beta] activation in recessive dystrophic epidermolysis bullosa Dystrophic epidermolysis bullosa: secondary disease mechanisms and disease modifiers Increased abundance of Cbl E3 ligases alters PDGFR signaling in recessive dystrophic epidermolysis bullosa Plantar involvement correlates with obesity, pain and impaired mobility in epidermolysis bullosa simplex: a retrospective cohort study Pro‐inflammatory immunity supports fibrosis advancement in epidermolysis bullosa: intervention with Ang‐(1‐7) Systemic collagen VII replacement therapy for advanced recessive dystrophic epidermolysis bullosa Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility Kindlin-2 mediates mechanical activation of cardiac myofibroblasts Natural history of growth and anaemia in children with epidermolysis bullosa: a retrospective cohort study Proteomic profiling of fibroblasts isolated from chronic wounds identifies disease-relevant signaling pathways Radiation-associated pemphigus vulgaris in a patient with preceding malignancy: treatment with rituximab as a valuable option Role of astacin-like proteinases in physiological and pathological wound healing and scarring Skin fragility: perspectives on evidence-based therapies STAT3 targeting in dystrophic epidermolysis bullosa The status quo of rare diseases centres for the development of a clinical decision support system - a cross-sectional study Uniparental disomy of chromosome 2 unmasks new ITGA6 recessive mutation and results in a lethal junctional epidermolysis bullosa in a newborn EGFR inhibition for metastasized cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa Die Bedeutung von Wissenschaftlichkeit für das Medizinstudium und die Promotion EGFR inhibition for metastasized cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa Treatment of keratinocytes with 4-phenylbutyrate in epidermolysis bullosa: Lessons for therapies in keratin disorders Mapping health care of rare diseases: the example of epidermolysis bullosa in Germany Combinatorial omics analysis reveals perturbed lysosomal homeostasis in collagen VII-deficient keratinocytes Conceptualization and implementation of the central information portal on rare diseases : protocol for a qualitative study Conceptualization and implementation of the central information portal on rare diseases: protocol for a qualitative study Conceptualization and implementation of the central information portal on rare diseases: Protocol for a qualitative study Metadata correction: Conceptualization and implementation of the central information portal on rare diseases: protocol for a qualitative study Successful multidisciplinary treatment of chronic facial wounds in junctional epidermolysis bullosa Targeting of cell surface proteolysis of collagen XVII impedes squamous cell carcinoma progression Interaction of Complement Defence Collagens C1q and Mannose-Binding Lectin with BMP-1/Tolloid-like Proteinases Interaction of complement defence collagens C1q and mannose-binding lectin with BMP-1/tolloid-like proteinases Mesenchymal stromal cell therapy for dystrophic epidermolysis bullosa Definitions and outcome measures for mucous membrane pemphigoid: recommendations of an international panel of experts Targeting epidermal lipids for treatment of Mendelian disorders of cornification Guidelines on the use of extracorporeal photopheresis Targeting epidermal lipids for treatment of Mendelian disorders of cornification Rat model for dominant dystrophic epidermolysis bullosa: glycine substitution reduces collagen VII stability and shows gene-dosage effect Prevalence of collagen VII-specific autoantibodies in patients with autoimmune and inflammatory diseases Prevalence of collagen VII-specific autoantibodies in patients with autoimmune and inflammatory diseases Prevalence of collagen VII-specific autoantibodies in patients with autoimmune and inflammatory diseases

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Leena Bruckner-Tuderman (1952-)

Dipeptidyl peptidase-4-mediated fibronectin processing evokes a pro-fibrotic extracellular matrix

Dipeptidylpeptidase-4-mediated fibronectin interaction promotes deposition of a profibrotic extracellular matrix

Pioneers in dermatology and venereology: an interview with Professor Leena Bruckner‐Tuderman

Safety and tolerability of losartan to treat recessive dystrophic epidermolysis bullosa in children (REFLECT): an open-label, single-arm, phase 1/2 trial

Identification of PCPE-2 as the endogenous specific inhibitor of human BMP-1/tolloid-like proteinases

Identification of PCPE-2 as the endogenous specific inhibitor of human BMP-1/tolloid-like proteinases

Pro‐inflammatory immunity supports fibrosis advancement in epidermolysis bullosa: intervention with Ang‐(1‐7)

Diversity ofmechanisms underlying latent TGF-[beta] activation in recessive dystrophic epidermolysis bullosa

Dystrophic epidermolysis bullosa: secondary disease mechanisms and disease modifiers

Increased abundance of Cbl E3 ligases alters PDGFR signaling in recessive dystrophic epidermolysis bullosa

Plantar involvement correlates with obesity, pain and impaired mobility in epidermolysis bullosa simplex: a retrospective cohort study

Pro‐inflammatory immunity supports fibrosis advancement in epidermolysis bullosa: intervention with Ang‐(1‐7)

Systemic collagen VII replacement therapy for advanced recessive dystrophic epidermolysis bullosa

Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility

Kindlin-2 mediates mechanical activation of cardiac myofibroblasts

Natural history of growth and anaemia in children with epidermolysis bullosa: a retrospective cohort study

Proteomic profiling of fibroblasts isolated from chronic wounds identifies disease-relevant signaling pathways

Radiation-associated pemphigus vulgaris in a patient with preceding malignancy: treatment with rituximab as a valuable option

Role of astacin-like proteinases in physiological and pathological wound healing and scarring

Skin fragility: perspectives on evidence-based therapies

STAT3 targeting in dystrophic epidermolysis bullosa

The status quo of rare diseases centres for the development of a clinical decision support system - a cross-sectional study

Uniparental disomy of chromosome 2 unmasks new ITGA6 recessive mutation and results in a lethal junctional epidermolysis bullosa in a newborn

EGFR inhibition for metastasized cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa

Die Bedeutung von Wissenschaftlichkeit für das Medizinstudium und die Promotion

EGFR inhibition for metastasized cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa

Treatment of keratinocytes with 4-phenylbutyrate in epidermolysis bullosa: Lessons for therapies in keratin disorders

Mapping health care of rare diseases: the example of epidermolysis bullosa in Germany

Combinatorial omics analysis reveals perturbed lysosomal homeostasis in collagen VII-deficient keratinocytes

Conceptualization and implementation of the central information portal on rare diseases : protocol for a qualitative study

Conceptualization and implementation of the central information portal on rare diseases: protocol for a qualitative study

Conceptualization and implementation of the central information portal on rare diseases: Protocol for a qualitative study

Metadata correction: Conceptualization and implementation of the central information portal on rare diseases: protocol for a qualitative study

Successful multidisciplinary treatment of chronic facial wounds in junctional epidermolysis bullosa

Targeting of cell surface proteolysis of collagen XVII impedes squamous cell carcinoma progression

Interaction of Complement Defence Collagens C1q and Mannose-Binding Lectin with BMP-1/Tolloid-like Proteinases

Interaction of complement defence collagens C1q and mannose-binding lectin with BMP-1/tolloid-like proteinases

Mesenchymal stromal cell therapy for dystrophic epidermolysis bullosa

Definitions and outcome measures for mucous membrane pemphigoid: recommendations of an international panel of experts

Targeting epidermal lipids for treatment of Mendelian disorders of cornification

Guidelines on the use of extracorporeal photopheresis

Targeting epidermal lipids for treatment of Mendelian disorders of cornification

Rat model for dominant dystrophic epidermolysis bullosa: glycine substitution reduces collagen VII stability and shows gene-dosage effect

Prevalence of collagen VII-specific autoantibodies in patients with autoimmune and inflammatory diseases

Prevalence of collagen VII-specific autoantibodies in patients with autoimmune and inflammatory diseases

Prevalence of collagen VII-specific autoantibodies in patients with autoimmune and inflammatory diseases